Introduction {#s0005}
============

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-related mortality worldwide.[@bib1] More than 600,000 people die from HCC each year.[@bib2] Although several major risk factors of HCC have been shown to contribute to hepatocarcinogenesis, the etiology is still unclear. Chronic inflammation developing through the action of various inflammatory mediators has been recently identified as a cofactor in carcinogenesis.[@bib3] Among inflammatory mediators, tumor necrosis factor-α (TNF-α) plays an essential role and has been implicated in inflammation-associated tumors.[@bib4]

TNF-α, produced by diverse kinds of cells, is 1 of the most important proinflammatory cytokines.[@bib5] Researchers have demonstrated that variation between individual TNF-α concentrations are attributed to single nucleotide polymorphisms (SNPs) in the TNF promoter region.[@bib6; @bib7] These SNPs have been reported to be associated with breast cancer,[@bib8] gastrointestinal cancer,[@bib9] prostate cancer,[@bib10] lung cancer,[@bib11] Graves disease,[@bib12] and Alzheimer disease.[@bib13]

During past years a number of case--control studies have been conducted to investigate the associations between TNF-α polymorphisms and HCC risk in humans, among which TNF-α-308 and -238 G/A polymorphisms are most highlighted and have been considered as risk factors for HCC.[@bib14; @bib15] But the findings from previous studies have been controversial. For example, Qin et al[@bib16] suggested that the TNF-α-308 G/A polymorphism is associated with a modest decrease in the risk of developing HCC, whereas Teixeira et al[@bib17] showed that the TNF-α-308 G/A polymorphism is significantly associated with higher risk of developing HCC. Tian et al[@bib18] provided convincing evidence that the TNF-α-238 G/A polymorphism is significantly associated with increased risk of developing HCC, whereas Heneghan et al[@bib19] failed to highlight specific associations between the 238 G/A polymorphisms tested and the risk of developing HCC. These discrepancies might be due to genetic trait differences and different linkage disequilibrium. Therefore, to derive a more comprehensive estimation of the associations between TNF-α polymorphisms and HCC risk, we conducted a meta-analysis to assess the association between TNF-α-308 and -238 G/A polymorphisms and HCC susceptibility in Asians.

Materials and Methods {#s0010}
=====================

Publication search {#s0015}
------------------

A computerized search of PubMed, EMBase, and China National Knowledge Infrastructure electronic databases was conducted to identify relevant articles published between 2003 and 2013 related to HCC risk and TNF-α-308 and -238 G/A polymorphisms. The key words were *hepatocellular carcinoma*, *liver cancer*, *polymorphism*, *variant*, and *tumor necrosis factor* or *TNF-α* as well as their combinations. The corresponding Chinese terms were used in the Chinese database. References of retrieved articles were checked for other eligible studies. The languages of selected articles were restricted to English and Chinese. The search was focused on studies that had been conducted in human beings. Only full-text articles and the most recent studies were included in our meta-analysis.

Selection criteria {#s0020}
------------------

The included studies met the following criteria: a case--control or cohort association study; confined to Asian populations; include at least 1 of the 2 SNPs, TNF-α-308, and TNF-α-238; results expressed as odds ratio (OR) and corresponding 95% CI; and genotype distribution of control for a certain polymorphism must be in Hardy-Weinberg equilibrium.

Data extraction {#s0025}
---------------

Two investigators independently extracted data and reached a consensus on all of the items. Any disagreement was resolved by discussing with the third expert. The following information was extracted from each article: first author, year of publication, total numbers of case patients and control subjects, and genotyping information. Furthermore, we examined if matching had been used and if the genotyping assay had been validated.

Statistical analyses {#s0030}
--------------------

Statistical analyses were carried out using Review Manager 5.2 (The Cochrane Collaboration, Oxford, United Kingdom). The crude ORs with 95% CIs were used to measure the associations between TNF-α polymorphisms and risk of HCC, which were calculated according to the method of Woolf. The significance of the pooled ORs was determined by the *z* test, and a *P* value \< 0.05 was considered statistically significant. The allelic model (A vs G) and genotype genetic models (codominant effects: AA vs GG; dominant effect: AA + AG vs GG; and recessive effect: AA vs AG + GG) were examined to evaluate the G/A allele with the risk of HCC. Heterogeneity of included studies was estimated using Cochran's *Q* test and *I*^2^ statistics. *P* values \< 0.1 and *I*^2^ \<50% were considered to be statistically significant.[@bib20] The fixed effects model was used when the effects were assumed to be homogenous, whereas the random effects model was used when they were heterogeneous. To assess if our results were substantially influenced by the presence of any individual study, we conducted a sensitivity analysis by systematically removing each study and recalculating the significance of the result. Funnel plots were used to evaluate publication bias. All *P* values were 2-tailed.

Results {#s0035}
=======

Study characteristics {#s0040}
---------------------

Two hundred thirteen articles were found with our search criteria. After discarding the duplicate research articles, 154 potential records concerned the topic. Following the title and abstract review, 40 full-text articles were preliminarily identified for further detailed evaluation. Overall, the initial search with the key words and the subject terms identified 17 articles (7 in Chinese and 10 in English) that met the inclusion criteria and were eligible for review. The study selection process is shown in [Figure 1](#f0005){ref-type="fig"}.

All 17 studies were identified to evaluate the relationship between the TNF-α-308 and -238 polymorphisms and risk for HCC. For the TNF-α-308 polymorphism, 14 relevant studies (4 in Chinese[@bib21; @bib22; @bib23; @bib24] and 10 in English[@bib19; @bib25; @bib26; @bib27; @bib28; @bib29; @bib30; @bib31; @bib32; @bib33]) with a total of 3154 cases and 3767 controls were included; for the TNF-α-238 polymorphism, 10 research articles (4 in Chinese[@bib22; @bib34; @bib35; @bib36] and 6 in English[@bib19; @bib22; @bib25; @bib29; @bib30; @bib32]) were identified, including 1388 cases and 2117 controls. Characteristics of the included studies are shown in [Table I](#t0005){ref-type="table"}. All the studies were conducted in persons of Asian descent. Furthermore, the genotype distributions among the control subjects of all studies were consistent with Hardy-Weinberg equilibrium.

Association between the TNF-α-308 G/A polymorphism and HCC {#s0045}
----------------------------------------------------------

The main results of meta-analysis of the association between the TNF-α-308 G/A polymorphism and HCC risk are shown in [Table II](#t0010){ref-type="table"}. Overall, the frequency of the A allele is higher in patients with HCC than in healthy controls (10.2% vs 7.5%). As shown in [Figures 2](#f0010){ref-type="fig"} and [3](#f0015){ref-type="fig"}, our results showed that there was a significant association between the TNF-α-308 G/A polymorphism and increased risk of HCC under allelic and dominant effects (A vs G: OR = 1.57; 95% CI, 1.22--2.01; *P* = 0.0004; AA + AG vs GG: OR = 1.62; 95% CI, 1.18--2.22; *P* = 0.003) in a random-effects model, indicating that being an A carrier may be a risk factor for developing HCC among Asians. However, under codominant effects and recessive effects, no significant associations were found (AA vs GG: OR = 1.15; 95% CI, 0.70--1.89; *P* = 0.57; AA vs AG + GG: OR = 1.12; 95% CI, 0.68--1.84; *P* = 0.65) in a fixed model.

Association between the TNF-α-238 G/A polymorphism and HCC {#s0050}
----------------------------------------------------------

[Table II](#t0010){ref-type="table"} shows the OR for HCC of TNF-α-238 G/A polymorphism with the variant genotypes. The heterogeneity between studies was significant and a random-effects model was employed. As shown in [Figures 4](#f0020){ref-type="fig"} and [5](#f0025){ref-type="fig"}, no significant associations were found in any genotypes (A vs G: OR = 1.06; 95% CI, 0.59--1.92; *P* = 0.85; AA vs GG: OR = 0.40; 95% CI, 0.05--2.92; *P* = 0.36; AA + AG vs GG: OR = 1.13; 95% CI, 0.68--1.89; *P* = 0.64; AA vs AG + GG: OR = 0.39; 95% CI, 0.05--3.02; *P* = 0.37). This demonstrated that this polymorphism was not associated with HCC risk.

Sensitivity analysis {#s0055}
--------------------

The influence of a single study on the overall meta-analysis estimate was investigated by omitting 1 study at a time, and the omission of any study made no significant difference, indicating that our results were statistically reliable.

Publication bias {#s0060}
----------------

The shape of the funnel plots was symmetrical, suggesting that there was no evidence of publication bias among these studies. [Figure 6](#f0030){ref-type="fig"} displayed funnel plots for the associations between the TNF-α-308 polymorphism and HCC. The statistical results still did not show publication bias.

Discussion {#s0065}
==========

Carcinogenesis of HCC is a complex process. The risk factors include chronic infection of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, carcinogen exposure, excessive alcohol consumption, and a variety of genetic factors.[@bib37] During recent decades, inflammation has been considered an important factor involved in carcinogenesis. TNF-α, the most crucial inflammatory cytokine, plays a very important role in inflammation and in the pathogenesis of cancer.[@bib38] Studies have demonstrated that TNF-α was not only involved in the pathogenesis of both hepatitis and liver cirrhosis,[@bib39; @bib40] but also involved in the development of HCC.[@bib41; @bib42] Moreover, TNF-α-308 and -238 polymorphisms have been reported to be related to risk of HCC because the G/A polymorphism can change the transcription of TNF-α and TNF-α production. However the results were inconsistent due to the rather small size and unified ethnicity. To provide further investigation into these controversial points, our meta-analysis was conducted to achieve a more reliable and comprehensive conclusion.

We investigated the association between TNF-α-308 and -238 polymorphisms and risk of HCC. A total of 17 studies were included, 14 for the TNF-α-308 polymorphism and 10 for the TNF-α-238 polymorphism. The results showed that the variant genotypes AA/AG of TNF-α-308 G/A were associated with a significantly increased HCC risk when compared with the GG genotype. Our result is consistent with a previous meta-analysis.[@bib43] However this association was limited to Asian populations. For the TNF-α-238 G/A polymorphism, no association was found among Asian people. This result was consistent with Zhou et al[@bib43] and Yang et al,[@bib44] but not consistent with Wei et al[@bib45] and Cheng et al.[@bib46] In this study, heterogeneity was found for TNF-α-308 and -238 polymorphisms, so a random-effects model was selected and sensitivity analysis was performed. By removing each study from our meta-analysis each time and rerunning the model to determine the effect on each overall estimate, we found quite little change. This confirmed the stability of our results.

Previous studies found that circulating TNF-α levels were elevated in patients with HCC.[@bib47; @bib48] It is reasonable to speculate that the high circulating TNF-α levels found in patients with HCC may be attributed to its SNPs. TNF-α may stimulate the release of other inflammatory cytokines and also induce the production of other fibrogenic factors, such as tumor growth factor-β, interleukin-1, and interleukin-6,[@bib49] which can cause or aggravate liver damage.[@bib6] Because HCC mostly occurs in Asia where HBV and HCV infections are endemic, the association between TNF-α-308 and -238 G/A polymorphisms and HCC are very important to identify persons in Asia at greater risk of developing HCC. Our meta-analysis was only conducted among an Asian population. Furthermore, the majority of HCCs are related to HBV and HCV infection, but most studies did not provide the number of patients with HBV or HCV infection, number of controls with HBV/HCV infection, or the number of patients with HHC. This suggests that clarifying the independent role of each polymorphism on HBV, HCV, and HCC is quite necessary and might explain the discrepancies with other studies. Moreover, a previous meta-analysis with relatively small sample size may have had insufficient statistical power to detect a slight effect or may have generated a fluctuated risk estimate.

Several limitations exist in our meta-analysis. First, environmental and genetic factors, such as HBV and HCV infection, should be considered because HCC is a multifactorial disease. Second, some other single-nucleotide polymorphisms of cytokines should be identified to determine the interacting functions. Third, there was significant heterogeneity among the studies in overall comparison models. According to the problems we addressed, further studies are needed to detect the independent role of each polymorphism.

Conclusions {#s0070}
===========

Our meta-analysis suggests that the TNF-α-308 polymorphism is associated with risk of HCC, although a significant association was not found between the TNF-α-238 polymorphism and HCC. Larger and more rigorous analytical studies are required to evaluate gene--environment interactions and to clarify the interaction between the TNF-α polymorphism and HBV infection status.
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![Funnel plots analysis to detect publication bias of this meta-analysis. Each point represents an independent study for the indicated association.](gr6){#f0030}

###### 

Main characteristic and genotype distributions of studies included in the meta-analysis.

  First author   Year   Country    Total   Genotype frequencies (GG/AG/AA)               
  -------------- ------ ---------- ------- --------------------------------- ----------- -----------
  TNF-α-308                                                                              
   Heneghan      2003   China      98      172                               88/10/0     158/13/1
   Wang          2003   Japan      125     204                               109/15/1    179/23/2
   Ho            2004   China      74      289                               37/34/3     225/62/2
   Chen          2005   China      572     381                               468/95/9    311/67/3
   Migita        2005   Japan      48      188                               47/1/0      183/5/0
   Kummee        2007   Thailand   50      150                               42/6/2      123/15/12
   Jeng          2007   China      108     108                               80/28/0     100/8/0
   Sakamoto      2008   Japan      209     275                               205/4/0     270/5/0
   Song          2009   China      81      78                                53/28/0     66/12/0
   Jeng          2009   China      200     200                               149/51/0    188/12/0
   Yang          2012   China      772     852                               619/145/8   683/160/9
   Wang CK       2012   China      620     625                               496/118/6   510/108/7
   Shi           2012   China      73      116                               51/20/2     84/30/2
   Wang          2012   China      124     129                               96/28/0     114/15/0
  TNF-α-238                                                                              
   Heneghan      2003   China      98      172                               96/2/0      168/4/0
   Wang          2003   Japan      125     204                               111/13/1    178/24/2
   Huang         2007   China      100     150                               88/12/0     143/7/0
   Kummee        2007   Thailand   50      150                               44/5/1      96/4/50
   Jeng          2007   China      108     108                               102/6/0     106/2/0
   Jeng          2009   China      200     200                               194/6/0     198/2/0
   Jung          2009   Korea      227     365                               193/34/0    336/28/1
   Wang          2010   China      230     513                               209/20/1    455/57/1
   Chen          2011   China      126     126                               120/6/0     115/11/0
   Wang          2012   China      124     129                               117/7/0     125/4/0

TNF-α= tumor necrosis factor-α.

###### 

Results of pooled odds ratios (ORs) in this meta-analysis.

  Genotype        Tumor necrosis factor-α-308   Tumor necrosis factor-α-238                                               
  --------------- ----------------------------- ----------------------------- --------------- -------------------- ------ ---------------
  A vs G          1.57 (1.22-- 2.01)            0.0004                        0.0002/67%      1.06 (0.59-- 1.92)   0.85   \<0.00001/78%
  AA vs GG        1.15 (0.70--1.89)             0.57                          0.38/7%         0.40 (0.05--2.92)    0.36   0.06/59%
  AA + AG vs GG   1.62 (1.18--2.22)             0.003                         \<0.00001/77%   1.13 (0.68--1.89)    0.64   0.001/67%
  AA vs AG + GG   1.12 (0.68--1.84)             0.65                          0.55/0%         0.39 (0.05--3.02)    0.37   0.05/61%
